Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
Ann Rheum Dis. 2021;80(9):1130-1136
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2021;80(9):1130-1136
Ann Rheum Dis. 2021 Jul 28:annrheumdis-2021-220651
Clin Rheumatol. 2021. Epub ahead of print doi: 10.1007/s10067-021-05853-x
Arthritis Rheumatol. 2021;73(7):1155–66
RMD Open. 2021;7(2):e001601.
Drug Saf. 2021 Feb 2. DOI: 10.1007/s40264-020-01036-w
ACR Open Rheumatol. 2021 Feb 11.
Annals of the rheumatic diseases. 2021 Mar 1;80(3):312-20.
Ann Rheum Dis 2021;80:96–102.
Rheumatology 2020; doi:10.1093/rheumatology/keaa576